Literature DB >> 8165973

[A nation-wide survey on the occurrence of Vogt-Koyanagi-Harada disease in Japan].

S Murakami1, Y Inaba, M Mochizuki, A Nakajima, A Urayama.   

Abstract

A nation-wide survey was performed to estimate the frequency and distribution of Vogt-Koyanagi-Harada's disease (Harada's disease hereinafter). A questionnaire was mailed to the departments of ophthalmology in hospitals with at least 200 beds. The response rate was 489 out of 1,077 institutions, or 45.4%. The annual prevalence was estimated to be 15.5 per million and the incidence was 6.5 per million, based on the number of reported cases and the response rate per prefecture. It was estimated that 1,800 patients were treated for this disease annually and that there were about 800 new cases. Geographical distribution showed no special characteristics such as these seen with Behçet's disease. The results of the analysis of 1,833 cases showed that females were slightly more affected than males, with an age distribution on first visit which showed a peak in the fourth decade and with the median age being 42.3 years.

Entities:  

Mesh:

Year:  1994        PMID: 8165973

Source DB:  PubMed          Journal:  Nippon Ganka Gakkai Zasshi        ISSN: 0029-0203


  3 in total

1.  Alterations of color vision and central visual field in patients with Vogt-Koyanagi-Harada syndrome.

Authors:  Peizeng Yang; Min Sun; Xiaoli Liu; Hongyan Zhou; Wang Fang; Li Wang; Aize Kijlstra
Journal:  J Ophthalmic Inflamm Infect       Date:  2012-02-02

2.  Determination of Genes Related to Uveitis by Utilization of the Random Walk with Restart Algorithm on a Protein-Protein Interaction Network.

Authors:  Shiheng Lu; Yan Yan; Zhen Li; Lei Chen; Jing Yang; Yuhang Zhang; Shaopeng Wang; Lin Liu
Journal:  Int J Mol Sci       Date:  2017-05-13       Impact factor: 5.923

3.  Decreased B and T lymphocyte attenuator in Behcet's disease may trigger abnormal Th17 and Th1 immune responses.

Authors:  Zi Ye; Bolin Deng; Chaokui Wang; Dike Zhang; Aize Kijlstra; Peizeng Yang
Journal:  Sci Rep       Date:  2016-02-04       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.